In our association of over three years with CliniRx, we are currently running our 5th consecutive study with them. What has impressed us most is their client focus and flexibility. Their team has blended well with ours; and together it feels like one common team united by their commitment and enthusiasm for the study’s success. They are extremely flexible and are very responsive to our requests in order to ensure that the timelines are met.
We value our association and would be willing to consider CliniRx again for future collaborations in clinical development.
Sheila Weir
Project Director
Newron Pharmaceuticals SpA
I am happy to put on record my appreciation for the CliniRx team. Thanks to them, our study was submitted to the regulatory authorities (ECs and at the DCGI) within a day of finalization of the documents. The meticulous planning and knowledge of the regulatory requirements that went into this is highly appreciated. Your project Managers, as well as the CRAs are doing an excellent job with the enrollment goals and expectations. Good to see that the sites are promptly entering the data in the e-CRF, and is being monitored closely by your team.
Additionally, I would also like to acknowledge your medical team for providing medical oversight and therapeutic area expertise to the study. The therapeutic expertise within your team is unique, and is well appreciated, especially with the interactions at the sites and with the Principle Investigators, all culminating in the successful completion of the study.
Munaf Ali, PhD.
Managing Director
Munaf Ali Consultancy Limited
CliniRx did an excellent job in executing the quality plan for our Asia region sites. I am indebted to you and your team for the excellent work you performed to ensure our clinical study was conducted in compliance and produced the quality data.
Director, Global Clinical Operations of a Biotech company, New York
